Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
16.84%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 1.65Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information
Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCOHERUS ONCOLOGY INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CHRS - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 142.77M | $ 24.05M | 16.84% |
| 3/31/2025 | $ 197.5M | $ 25.86M | 13.09% |
| 12/31/2024 | $ 266.96M | $ 27.8M | 10.41% |
| 9/30/2024 | $ 304.34M | $ 32.22M | 10.59% |
| 6/30/2024 | $ 308.13M | $ 35.3M | 11.46% |
| 3/31/2024 | $ 301.87M | $ 38.15M | 12.64% |
| 12/31/2023 | $ 257.24M | $ 43.11M | 16.76% |
| 9/30/2023 | $ 211.07M | $ 44.04M | 20.86% |
| 6/30/2023 | $ 181.93M | $ 46.37M | 25.49% |
| 3/31/2023 | $ 183.36M | $ 50.14M | 27.34% |
Key Performance Insights, Last 5 Years
- COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) SB Comp % stands at 7.27%.
- Over the past 5 years, COHERUS ONCOLOGY INC's average SB Comp % has been 15.56%.
- The median SB Comp % for COHERUS ONCOLOGY INC during this period was 14.71%
- COHERUS ONCOLOGY INC reached its highest SB Comp % over the past 5 years at 27.34%.
- The lowest SB Comp % recorded by COHERUS ONCOLOGY INC in the same timeframe 7.27%
COHERUS ONCOLOGY INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for COHERUS ONCOLOGY INC is calculated as follows: SB Comp. [ $ 35.56M ] / Revenues [ $ 489.26M ]
(=) SB Comp % [ 7.27% ] CHRS - Stock Based Compensation Margin, Last 5 years
7.27%
Minimum
Sep 30, 2020
27.34%
Maximum
Mar 31, 2023
15.56%
Average
14.71%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |